Ketamine for
Chronic Back Pain in Baltimore
Targeting the neurological amplifier — not the disc, not the vertebra, but the nervous system that won't stop hurting
Ketamine for chronic back pain in Baltimore costs $1,499.99 per session ($1,125 for Vitality Circle members — a $374.99 saving) and is anesthesiologist-led care, under the medical direction of Dr. Brijen Joshi MD, a board-certified Johns Hopkins anesthesiologist. This off-label infusion targets the central sensitization component of back pain — the NMDA receptor hyperactivity that makes pain disproportionate to structural findings, or that persists after structural treatment. It is most clearly indicated for failed back surgery syndrome (FBSS) — pain persisting after technically successful spine surgery — and for patients whose pain far exceeds what their imaging shows. For patients on long-term opioids, ketamine also directly counteracts opioid-induced hyperalgesia through NMDA blockade. Ketamine does not repair herniated discs, spinal stenosis, or other structural spine pathology.
Mon–Fri: 1PM–8PM · Sat: 10AM–2PM
513 Bayview Blvd, Canton Baltimore MD 21224
(443) 563-1059
Tell Us About Your Situation
Answer a few quick questions — our clinical team reaches out within 1 business day to discuss whether ketamine therapy may be right for you.
Your information is confidential. A clinical team member follows up within 1 business day.
Structural Back Pain vs. Central Sensitization — Two Different Problems
Chronic back pain is the most common chronic pain condition in the United States — affecting approximately 65 million Americans. But not all chronic back pain is the same, and understanding the distinction between structural back pain and central sensitization is the key to understanding whether ketamine evaluation is appropriate for your specific situation.
The honest answer is that ketamine is not right for every back pain patient. It is right for the patient whose pain involves central sensitization — and wrong, or at least premature, for the patient whose structural pathology hasn't been adequately addressed.
If correctable structural pathology is present and has not been adequately addressed — through physical therapy, interventional pain procedures, or surgery where indicated — that is the primary conversation to have with a spine surgeon or interventional pain specialist. Ketamine cannot fix mechanical compression, nerve impingement, or structural instability.
When back pain persists after structural treatment, when pain intensity significantly exceeds what imaging shows, or when the pain has a neuropathic quality (burning, electric, widespread sensitivity), central sensitization is likely a major driver. NMDA receptors in the spinal cord become hyperactive — amplifying pain signals independently of the peripheral structural source. This is the mechanism ketamine's NMDA blockade directly targets.
Failed Back Surgery Syndrome — When Surgery Fixed the Structure but Not the Pain
Failed back surgery syndrome (FBSS) — also called post-laminectomy syndrome — is among the most frustrating and debilitating chronic pain conditions a patient can experience. The surgery went well. The imaging shows a corrected structure. But the pain persisted, or returned, or became worse.
of patients who undergo lumbar spine surgery develop FBSS — persistent or recurrent pain after technically successful surgery. (Thomson S. Failed back surgery syndrome — definition, epidemiology and demographics. Br J Pain 2013;7(1):56-9. PubMed)
The mechanism of FBSS is well-understood: chronic back pain, if present for long enough before surgery, causes NMDA receptors in the spinal cord to become hyperactive. The nervous system begins generating and amplifying pain signals independently of the peripheral structural source — a self-sustaining central sensitization loop. When surgery corrects the disc herniation, the stenosis, or the instability, it addresses the peripheral generator. But it cannot reset the sensitized spinal cord.
Chronic structural pain: the longer back pain exists before surgery, the more likely NMDA receptor hyperactivity is to have developed in the spinal cord — the nervous system adapts to chronic pain by lowering its pain threshold and amplifying signals.
Surgery addresses the structure: disc herniation corrected, stenosis decompressed, instability fused. The peripheral structural generator is removed — technically successful by every surgical metric.
Central sensitization persists: the sensitized spinal cord continues generating pain independently — now without a peripheral source to explain it. The patient wakes from surgery with pain, or has initial relief followed by return of pain weeks later.
Ketamine targets what surgery cannot: NMDA receptor blockade directly interrupts the spinal cord hyperactivity maintaining FBSS — the mechanism that surgery, by its nature, cannot address. A series of infusions may reset the central sensitization that has been self-sustaining since before the operation.
Opioid-Induced Hyperalgesia — When the Pain Medication Makes the Pain Worse
Chronic back pain patients are disproportionately likely to be on long-term opioid therapy — and many have noticed that their pain has become more widespread, more intense, or less responsive to opioid doses over time. This is not always tolerance. For many patients, it is opioid-induced hyperalgesia — a distinct and treatable mechanism that ketamine directly addresses.
Opioid-induced hyperalgesia (OIH) is a paradoxical phenomenon — where long-term opioid use produces increased pain sensitivity rather than analgesia. Patients on long-term opioids for back pain may find that their pain becomes more widespread, that new areas of the body become painful, that pain intensity increases despite dose escalation, and that the character of pain shifts from localized to diffuse and burning. These are hallmarks of OIH rather than opioid tolerance — and the treatment is not dose escalation.
The mechanism: chronic opioid exposure upregulates NMDA receptors through neuroplastic changes in spinal cord pain processing pathways — paradoxically increasing central sensitization. The same receptors that ketamine blocks are the receptors that long-term opioids cause to proliferate. This is why ketamine is used perioperatively in opioid-tolerant surgical patients — to counteract OIH and restore analgesic sensitivity.
How Ketamine Addresses OIH
Ketamine directly blocks the upregulated NMDA receptors that chronic opioid use has proliferated — potentially reversing the central sensitization that OIH produces. For back pain patients on long-term opioids whose pain has worsened or become more diffuse over time, ketamine's NMDA mechanism addresses OIH through a pathway that no opioid dose increase, opioid rotation, or opioid taper can reach. Opioid management continues under the prescribing physician's direction — no changes are made by Vita Nova.
References: Angst MS, Clark JD (2006). Opioid-induced hyperalgesia: a qualitative systematic review. Anesthesiology 104(3):570-87. PubMed · Mao J (2002). Opioid-induced abnormal pain sensitivity: implications in clinical opioid therapy. Pain 100(3):213-7. PubMed · Joly V et al. (2005). Remifentanil-induced postoperative hyperalgesia and its prevention with small-dose ketamine. Anesthesiology 103(1):147-55. PubMed
The Mechanism — NMDA Blockade in the Chronic Back Pain Context
Spinal Cord Dorsal Horn NMDA Blockade
The primary analgesic mechanism of ketamine in chronic back pain is blockade of NMDA receptors in the spinal cord dorsal horn — the synaptic relay station through which peripheral pain signals from the back are transmitted to the brain. In central sensitization, these receptors are pathologically hyperactive — transmitting and amplifying pain signals at far greater intensity than the peripheral input warrants. Ketamine's NMDA blockade interrupts this hyperactivity directly — both during the infusion and, through the plastic changes a series of infusions produces, potentially beyond the infusion period itself.
Wind-Up Interruption in Chronic Neuropathic Back Pain
Neuropathic back pain — including radiculopathy from nerve root compression, post-surgical nerve damage, and sensitized spinal cord pathways — involves temporal summation (wind-up), where repeated pain signals progressively amplify through NMDA-mediated long-term potentiation. This is the mechanism that turns a tolerable back ache into the searing, electric pain that radicular and post-surgical patients describe. Ketamine interrupts wind-up at the NMDA receptor level — the only commonly available treatment that directly addresses this specific amplification mechanism. If your pain is mainly leg-dominant — shooting from the buttock down the leg along the sciatic nerve — see our dedicated ketamine for sciatica in Baltimore page; this page covers axial back and spine pain, FBSS, and opioid-induced hyperalgesia.
NMDA Blockade Reversing Opioid-Induced Hyperalgesia
For patients on long-term opioids, ketamine's NMDA blockade addresses the receptor upregulation that OIH produces — potentially restoring some of the analgesic sensitivity that chronic opioid exposure has eroded. This anti-hyperalgesic effect is well-documented in the surgical anesthesia literature and is the basis for ketamine's use as an opioid-sparing agent in opioid-tolerant patients.
Descending Pain Inhibition Restoration
Chronic back pain — particularly when co-occurring with depression — is associated with impaired descending pain inhibition: the brain's natural ability to dampen spinal cord pain signal transmission is reduced. Ketamine's glutamate-driven synaptogenesis in prefrontal circuits may restore some descending inhibitory function, reducing pain not just at the spinal level but through restored supraspinal control. This makes ketamine particularly relevant for back pain patients with co-occurring depression.
Patient Selection & Clinical Evidence
Patient selection is the most important clinical variable in ketamine for chronic back pain. The strongest candidates are those with clear central sensitization features.
✓ Strongest Candidates for Evaluation
- Failed back surgery syndrome — persistent pain after technically successful surgery
- Pain intensity significantly exceeds imaging findings — hallmark of central sensitization
- Neuropathic pain quality — burning, electric, widespread sensitivity, allodynia
- Long-term opioid therapy with worsening or diffuse pain — consistent with OIH
- Co-occurring depression or PTSD — ketamine addresses both simultaneously
- Conservative and interventional approaches exhausted without adequate relief
— Weaker Candidates — Other Treatment First
- Active, correctable structural pathology not yet addressed — spine surgery or interventional procedure should be considered first
- Recent acute disc herniation — conservative treatment should precede ketamine evaluation
- Pain well-controlled on current regimen — ketamine is for refractory presentations
- No features of central sensitization or neuropathic involvement — pure mechanical pain without CS features is less amenable
Randomized, double-blind trial of 40 patients with chronic neuropathic pain after spinal cord injury — a central sensitization pain state of spinal origin. Adding a daily five-hour low-dose ketamine infusion for one week to oral gabapentin significantly reduced pain scores compared with gabapentin alone, and the benefit persisted for about two weeks after the infusions stopped before fading. It is one of the clearest controlled demonstrations that a multi-day ketamine series can reset spinal-level pain amplification — the same mechanism targeted in FBSS — and it is also an honest reminder that durability varies and repeat series may be needed.
Systematic review establishing opioid-induced hyperalgesia as a distinct clinical phenomenon — differentiating OIH from tolerance and documenting the NMDA-mediated mechanism of OIH in chronic opioid users. Foundational evidence for the anti-hyperalgesic rationale of ketamine in opioid-tolerant back pain patients.
Randomized, double-blind trial of 75 surgical patients showing that a large intraoperative opioid (remifentanil) dose produced measurable postoperative hyperalgesia — a wider area of hypersensitivity around the incision and higher morphine needs — and that small-dose ketamine prevented it, implicating an NMDA-mediated pain-facilitation process. The perioperative context provides the strongest translational evidence for ketamine's anti-OIH mechanism in the chronic back pain and opioid-tolerant population.
The foundational paper establishing NMDA receptors as the central mechanism of central sensitization — directly applicable to the chronic back pain population where central sensitization maintains pain independent of structural findings. Provides the mechanistic substrate for why NMDA-targeted therapy reaches what conventional analgesics, injections, and surgery cannot.
Co-Occurring Depression & Pricing at Vita Nova
Depression co-occurs in approximately 40% of patients with chronic back pain — and it is not merely a psychological response to living with pain. Depression activates descending pain facilitation pathways that amplify back pain signals and removes the motivation for the physical rehabilitation that chronic back pain recovery requires. Ketamine's dual mechanism addresses both simultaneously.
When depression co-occurs with chronic back pain: ketamine's glutamate-NMDA mechanism may reach both through a shared pathway — the same NMDA blockade that interrupts spinal central sensitization also drives the prefrontal synaptogenesis associated with mood improvement, while helping restore the impaired descending pain inhibition that depression disrupts. See our co-occurring depression & chronic pain page.
| Service | Non-Member | Vitality Circle Member | Saving |
|---|---|---|---|
| Ketamine — Chronic Pain / session Off-Label | $1,499.99 | $1,125 | $374.99/session |
Self-pay, with a superbill. Vita Nova is self-pay for ketamine. Each $1,499.99 session is a private, continuously monitored infusion under the medical direction of Dr. Brijen L. Joshi MD, a board-certified Johns Hopkins anesthesiologist — physician-led care, not a nurse-only or spa drip. Vitality Circle membership ($99.99/month) lowers each session to $1,125; the $374.99 saved covers the membership on a single visit, and members also receive 25% off premium IVs (NAD+, high-dose Vitamin C, Iron) plus one included monthly perk (1 standard IV drip, 2 IM shots, 2 IV pushes, or 1 shot + 1 push). We provide an itemized superbill you can file with your insurance. HSA/FSA accepted; Community Heroes discounts available. Number of sessions determined individually. Pricing August 2026 — subject to change. Full pricing guide →
Complementary Treatments Supporting Chronic Back Pain Relief
Several wellness services at Vita Nova address physiological factors that amplify chronic back pain. Always discuss with your pain management provider before beginning supplemental therapy.
Magnesium naturally modulates NMDA receptor sensitivity — directly relevant to ketamine's central sensitization mechanism. Magnesium deficiency is common in chronic pain patients and worsens NMDA receptor excitability. For patients on long-term opioids, magnesium depletion may additionally worsen OIH by further sensitizing NMDA receptors.
B12 is essential for myelin synthesis and nerve conduction — directly relevant to the neuropathic component of radicular back pain and post-surgical nerve damage. B12 deficiency from long-term medication use is common in chronic back pain patients and worsens neuropathic symptoms alongside the structural pain.
Long-term opioid use depletes NAD+ reserves — contributing to the fatigue, cognitive fog, and mood dysregulation that many chronic back pain patients on opioids experience. NAD+ IV Therapy supports mitochondrial energy restoration relevant to both the neurological demands of chronic pain management and recovery from long-term opioid effects.
Iron-deficiency anemia is common in chronic back pain patients — particularly those with limited mobility or on long-term medications — and drives the fatigue and reduced exercise tolerance that undermine physical rehabilitation. Iron deficiency is also a recognized contributor to restless legs syndrome, which worsens nocturnal discomfort. Iron IV infusion restores iron stores faster than oral supplements when labs confirm a deficiency.
Inflammatory back pain — from discogenic inflammation, facet joint inflammation, or sacroiliac joint dysfunction — involves elevated pro-inflammatory cytokines that drive both peripheral and central pain sensitization. High-dose IV Vitamin C's anti-inflammatory signaling addresses cytokine load relevant to inflammatory spine pain components.
Clinical note: These wellness services are not treatments for chronic back pain and are not part of Vita Nova's ketamine protocols. Always discuss supplemental therapy with your pain management provider — particularly regarding interactions with opioid medications.
Special Pricing for Those Who Serve
Veterans, law enforcement, firefighters, and construction and healthcare workers carry disproportionate rates of occupational back injuries. Many have had surgeries that did not provide the expected relief.
Chronic Back Pain & Ketamine — Questions Answered
Common questions from patients with chronic back pain evaluating ketamine therapy in Baltimore.
The Surgery Fixed the Structure.
We Target What It Could Not —
If your back pain persisted after surgery, or if your pain far exceeds what your imaging shows, or if long-term opioids have made the pain worse — ketamine's NMDA mechanism reaches the central sensitization that no structural intervention can address. Off-label, self-pay with an itemized superbill you can file with your insurance. Community Heroes discounts available.
Canonical URL: https://vitanovawellnessclinic.com/ketamine-back-pain-baltimore/ · Last reviewed August 26, 2026
Medically reviewed by Dr. Brijen L. Joshi MD — Assistant Professor of Anesthesiology & Critical Care Medicine, Johns Hopkins University School of Medicine · Chief of Thoracic Anesthesia, Johns Hopkins Hospital · Medical Director, Vita Nova Ketamine & Wellness Clinic. · View full credentials →
